Ramucirumab 100 mg/10 mL Suppliers & Bulk Manufacturers
Available Forms: Solutions for disinfection
Available Strengths: 100 mg/10 mL
Reference Brands: Cyramza (USA/India)
Category: Oncology Cancer Care
Ramucirumab is a Oncology Cancer Care product available as Solutions for disinfection in strengths 100 mg/10 mL. It corresponds to the reference brand Cyramza (USA/India). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Gastric cancer, also known as stomach cancer, is one of the most common malignancies affecting people worldwide. It ranks among the leading cancers in both men and women, with significant prevalence in regions such as East Asia, parts of Europe, and Latin America. Countries like Japan, China, and several areas in Southern and Eastern Europe report higher rates of this disease, making it an important global health concern. Differences in lifestyle, diet, environmental factors, and genetics are believed to contribute to the variation in incidence across different populations.
In the United States, gastric cancer occurs less frequently compared to some other regions, but certain populations show higher diagnosis rates. These include Hispanic-Americans, African-Americans, Asians, and Pacific Islanders compared with non-Hispanic white populations. The disease is most commonly diagnosed in older adults, with the median age at diagnosis being around the late sixties. Despite advances in detection and treatment, gastric cancer can still be challenging to manage, as it is often diagnosed at an advanced stage.
Survival outcomes depend on factors such as stage at diagnosis, overall health of the patient, and response to treatment. Ongoing research and improved therapeutic approaches continue to focus on early detection and more effective treatment options to improve long-term outcomes for patients.
Ramucirumab — third party manufacturing & bulk supply
Ramucirumab 100 mg/10 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Ramucirumab is supplied as Solutions for disinfection — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ramucirumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ramucirumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ramucirumab is used for the treatment of several advanced cancers, including gastric or gastroesophageal junction cancer, metastatic colorectal cancer, non-small cell lung cancer, and hepatocellular carcinoma. It is often used alone or in combination with chemotherapy when the disease has progressed after prior treatment.
Ramucirumab is a fully human monoclonal antibody produced using recombinant DNA technology in mammalian cell culture systems. It is designed to specifically target vascular endothelial growth factor receptor-2 (VEGFR-2).
The primary trade name of Ramucirumab is Cyramza.
Ramucirumab (Cyramza) is developed and marketed by Eli Lilly and Company.
The generic name is Ramucirumab.
The main brand name is Cyramza.
Ramucirumab is manufactured in GMP-certified biologics manufacturing facilities approved by regulatory authorities such as the US FDA, EMA, and other international agencies, depending on the region of supply.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View DetailsVorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View DetailsPanobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View DetailsGilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers